Study Group: Neurologists who Specialize in Neuropathic Pain (?)
Council Members in this Study Group: 31
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Request a survey with this Study Group
Related Study Groups
| Study Group Name | Members |
|---|---|
| Neurologists | 1830 |
| Pain Physicians (US) | 526 |
| Neurologists (US) | 1087 |
| Neurologists who Treat Epilepsy (US) | 333 |
| Attending-Level Neurologists at Academic Medical Centers (US) | 549 |
| Neurologists who Treat Alzheimer's Disease (US) | 206 |
| Physicians who Treat Neuropathy (US) | 116 |
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Analysis of:
Shire Receives Approvable Letter from FDA for INTUNIV(TM) (guanfacine) Extended Release, a Nonstimulant for the Treatment of ADHD | www.pipelinereview.com
This is a helpful agent in ADHD for hyperactive symptoms. A long-acting form is critical in ADHD so no doses need to interrupt the school day. More even blood levels also an advantage.
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Academic Institution*
- Non-Academic Community Hospital or Clinic
- Consultancy, Healthcare-Focused
- Government/Military Hospital or Clinic
- Pharmaceuticals Manufacturer
- Strategic Management
Most Common Job Types:
- Physician - Attending Physician
- Physician - Director
- Director
- Principal
- Professor
- Researcher
- President
- Physician - Division Head
- Consultant
- Owner
GLG's 850+ Clients Include:
Fortune 500®
companies
40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
global private equity firms
5 of the top 10
AmLaw firms